BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25427924)

  • 1. Use of systemic therapy in the treatment of choroidal metastases from breast cancer.
    Alzouebi M; Ramakrishnan S; Rennie I; Salvi S
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25427924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of bilateral choroidal metastases of breast cancer to therapy with trastuzumab.
    Munzone E; Nolè F; Sanna G; Goldhirsch A
    Breast; 2005 Oct; 14(5):380-3. PubMed ID: 16216740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER2 and response to paclitaxel in node-positive breast cancer.
    Ferretti G; Felici A; Cognetti F
    N Engl J Med; 2008 Jan; 358(2):197; author reply 198. PubMed ID: 18184969
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bi-weekly nab-paclitaxel and trastuzumab therapy effective against recurrent breast cancer with multiple lung metastases in elderly patient who had previously undergone two chemotherapeutic regimens for treatment of metastatic disease-a case Report].
    Sakurai T; Jinta E; Suzuma T; Yoshimura G; Umemura T; Sakurai T
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1703-6. PubMed ID: 23152023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination treatment with trastuzumab and Paclitaxel as primary therapy for advanced breast cancer].
    Suzuki M; Kimijima I; Ishii M
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1519-23. PubMed ID: 19755824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2 and response to paclitaxel in node-positive breast cancer.
    Mehta R
    N Engl J Med; 2008 Jan; 358(2):197-8; author reply 198. PubMed ID: 18193531
    [No Abstract]   [Full Text] [Related]  

  • 7. Dramatic response of choroidal metastases from breast cancer to a combination of trastuzumab and vinorelbine.
    Wong ZW; Phillips SJ; Ellis MJ
    Breast J; 2004; 10(1):54-6. PubMed ID: 14717761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced complete regression of choroidal metastases and subsequent isolated leptomeningeal carcinomatosis in advanced breast cancer: a case report and literature review.
    Kosmas C; Malamos NA; Tsavaris N; Antonopoulos M
    J Neurooncol; 2000 Apr; 47(2):161-5. PubMed ID: 10982158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.
    Tolaney SM; Barry WT; Dang CT; Yardley DA; Moy B; Marcom PK; Albain KS; Rugo HS; Ellis M; Shapira I; Wolff AC; Carey LA; Overmoyer BA; Partridge AH; Guo H; Hudis CA; Krop IE; Burstein HJ; Winer EP
    N Engl J Med; 2015 Jan; 372(2):134-41. PubMed ID: 25564897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete regression of choroidal metastases from breast cancer after docetaxel-based systemic chemotherapy.
    Kosmas C; Malamos NA; Antonopoulos M
    Med Pediatr Oncol; 2000 Mar; 34(3):229-30. PubMed ID: 10696136
    [No Abstract]   [Full Text] [Related]  

  • 11. HER2 and response to paclitaxel in node-positive breast cancer.
    Roukos DH
    N Engl J Med; 2008 Jan; 358(2):197; author reply 198. PubMed ID: 18193530
    [No Abstract]   [Full Text] [Related]  

  • 12. Central nervous system progression during systemic response to trastuzumab, humanized anti-HER-2/neu antibody, plus paclitaxel in a woman with refractory metastatic breast cancer.
    Lindrud S; Orlick M; Barnard N; Hait WN; Toppmeyer DL
    Breast J; 2003; 9(2):116-9. PubMed ID: 12603385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of choroidal hemangioma following systemic paclitaxel and trastuzumab use.
    Kiratli H; Uzun S; Tarlan B
    Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):177-9. PubMed ID: 24297390
    [No Abstract]   [Full Text] [Related]  

  • 14. HER2 and response to paclitaxel in node-positive breast cancer.
    Nash I
    N Engl J Med; 2008 Jan; 358(2):198; author reply 198-9. PubMed ID: 18193532
    [No Abstract]   [Full Text] [Related]  

  • 15. [BREAST-CONSERVING SURGERY AFTER NEOADJUVANT THERAPY FOR BREAST CANCER].
    Semiglazov VF; Semiglazov VV; Petrenko OL; Komyakhov AV; Dashyan GA; Paltuev RM; Semiglazova TY; Manikhas AG; Bozhok AA; Lalak IA
    Vopr Onkol; 2015; 61(3):381-6. PubMed ID: 26242149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choroidal metastases. Case 1: breast cancer.
    Piccone MR; Maguire AM; Fox KC; Gendron K
    J Clin Oncol; 1999 Oct; 17(10):3356-8. PubMed ID: 10506638
    [No Abstract]   [Full Text] [Related]  

  • 17. Choroidal and optic disc metastases from breast cancer and their response to combination pharmacotherapy with tamoxifen, cyclophosphamide hydrate, letrozole, and bevacizumab.
    Zako M; Takeyama M; Naito E; Mizumoto K; Iwaki M
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):89-93. PubMed ID: 22011078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choroid metastasis of undifferentiated nasopharyngeal carcinoma.
    Ozyar E; Kiratli H; Akbulut S; Uzal D; Atahan IL
    J Laryngol Otol; 1998 Jul; 112(7):667-9. PubMed ID: 9775302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer.
    Burris H; Yardley D; Jones S; Houston G; Broome C; Thompson D; Greco FA; White M; Hainsworth J
    J Clin Oncol; 2004 May; 22(9):1621-9. PubMed ID: 15117984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic therapy for early-stage HER2-positive breast cancers: time for a less-is-more approach?
    Paplomata E; Nahta R; O'Regan RM
    Cancer; 2015 Feb; 121(4):517-26. PubMed ID: 25346473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.